GBT Trademark

Trademark Overview

On Tuesday, November 21, 2017, a trademark application was filed for GBT with the United States Patent and Trademark Office. The USPTO has given the GBT trademark a serial number of 87982665. The federal status of this trademark filing is REGISTERED as of Tuesday, March 10, 2020. This trademark is owned by Global Blood Therapeutics, Inc.. The GBT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
gbt

General Information

Serial Number87982665
Word MarkGBT
Filing DateTuesday, November 21, 2017
Status700 - REGISTERED
Status DateTuesday, March 10, 2020
Registration Number6008630
Registration DateTuesday, March 10, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 6, 2018

Trademark Statements

Description of MarkThe mark consists of the letters "GBT" followed by three connected hexagons positioned on the top right corner.
Goods and ServicesPharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
Pseudo MarkGLOBAL BLOOD THERAPEUTICS
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 4, 2017
Primary Code005
First Use Anywhere DateTuesday, December 17, 2019
First Use In Commerce DateTuesday, December 17, 2019

Trademark Owner History

Party NameGlobal Blood Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Thursday, November 17, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 17, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 17, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 17, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 17, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 4, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, September 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 10, 2020REGISTERED-PRINCIPAL REGISTER
Friday, February 7, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, February 6, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 5, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, February 4, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 7, 2020USE AMENDMENT FILED
Tuesday, February 4, 2020DIVISIONAL PROCESSING COMPLETE
Tuesday, January 7, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, February 4, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 7, 2020TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, January 7, 2020TEAS STATEMENT OF USE RECEIVED
Friday, September 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2019SOU EXTENSION 3 GRANTED
Wednesday, September 25, 2019SOU EXTENSION 3 FILED
Wednesday, September 25, 2019TEAS EXTENSION RECEIVED
Tuesday, March 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 8, 2019SOU EXTENSION 2 GRANTED
Friday, March 8, 2019SOU EXTENSION 2 FILED
Friday, March 8, 2019TEAS EXTENSION RECEIVED
Thursday, September 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 25, 2018SOU EXTENSION 1 GRANTED
Tuesday, September 25, 2018SOU EXTENSION 1 FILED
Tuesday, September 25, 2018TEAS EXTENSION RECEIVED
Tuesday, April 3, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 27, 2017ASSIGNED TO EXAMINER
Tuesday, December 5, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, December 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 24, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

treatment preparations pharmaceutical hypoxic conditions disease hypoxemic such hematological disorders